Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

3,010JPY
7:00am BST
Price Change (% chg)

¥11 (+0.37%)
Prev Close
¥2,999
Open
¥2,999
Day's High
¥3,030
Day's Low
¥2,981
Volume
451,100
Avg. Vol
880,870
52-wk High
¥3,075
52-wk Low
¥1,905

4519.T

Chart for 4519.T

About

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company operates in two business segments. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transporta... (more)

Overall

Beta: 0.69
Market Cap (Mil.): ¥1,678,498.00
Shares Outstanding (Mil.): 559.69
Dividend: 23.00
Yield (%): 1.50

Financials

  4519.T Industry Sector
P/E (TTM): 26.91 35.59 35.92
EPS (TTM): 111.43 -- --
ROI: 10.70 18.98 18.26
ROE: 11.00 19.75 19.14
Search Stocks

refile-TABLE-Chugai Pharm -Q1 group results (IFRS)

(Adds company forecast) Apr 24 - Chugai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Mar 31, 2014 Mar 31, 2013 Dec 31, 2014 LATEST YEAR-AGO COMPANY RESULTS RESULT FORECAST Sales 124.05 90

24 Apr 2014

Nikkei jumps over 2 pct after strong U.S. data; G20 in focus

* Market upbeat as Wall Street shrugs off weak China survey * Chugai Pharma jumps after Citigroup raises rating * G20, discussion on Fed tapering impact in focus By Ayai Tomisawa TOKYO, Feb 21 - Japan's Nikkei average jumped more than 2 percent on Friday, recouping most of the previous day's losses, as investors took heart from gains on Wall Street after a reading on U.S. manufacturing hit its highest in nearly four years. The Nikkei was up 2.2 percent at 14,765.67

21 Feb 2014

REFILE-TABLE-Chugai Pharm -2013 group results (IFRS)

(Adds company forecast) Jan 30 - Chugai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Dec 31, 2013 Dec 31, 2012 Dec 31, 2014 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULT FORECAST H1 FORECAST Sales 423.6

30 Jan 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
£10.00
Provider: MarketLine (a Datamonitor Company)
£114.00
Provider: GlobalData
£81.00
Provider: GlobalData
£81.00
Provider: GlobalData
£162.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks